GlassScriptPhysician profile
Charles A Iliya
NPI 1730204298
$2,868.75
in general payments reported to CMS, 2019-2025
32 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $138 · 2021: $14.22 · 2022: $479 · 2023: $272 · 2024: $368 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,051.67 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $292.05 | 2019-2024 | Caldolor |
| Allergan, INC. | $213.36 | 2019-2022 | |
| Ethicon US, LLC | $181.72 | 2019-2025 | Echelon Flex, Stratafix, Enseal |
| Integra Lifesciences Corporation | $140.76 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $130.30 | 2020-2025 | Phasix Mesh |
| Tela Bio, INC. | $109.62 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kls-Martin L.P. | $104.78 | 2019-2024 | |
| Abbvie INC. | $85.77 | 2023-2024 | |
| Medtronic, INC. | $63.00 | 2022-2024 | Signia, Progrip |
| Lemaitre Vascular, INC. | $43.68 | 2025 | Artegraft Vascular Graft |
| Kerecis Limited | $43.53 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Astrazeneca Pharmaceuticals LP | $38.16 | 2022-2024 | |
| Kci USA, INC. | $34.43 | 2019 | |
| W. L. Gore & Associates, INC. | $29.59 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $27.81 | 2025 | |
| Smith+Nephew, INC. | $27.41 | 2019 | |
| Hydrofera LLC | $23.04 | 2022 | |
| Solventum Corporation | $22.62 | 2025 | Activ.A.C. |
| Acelrx Pharmaceuticals, INC. | $20.77 | 2019 | |
| Avita Medical Americas, LLC | $19.15 | 2025 | Recell, Cohealyx, Permeaderm |
| La Jolla Pharmaceutical Company | $19.13 | 2024 | Giapreza |
| Mallinckrodt Enterprises LLC | $18.56 | 2019 | |
| Portola Pharmaceuticals, LLC | $16.53 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.19 | 2024 | Exparel |
| Advanced Oxygen Therapy INC. | $15.70 | 2023 | Topical Oxygen Chamber For Extremities |
| Ambu INC. | $14.62 | 2022 | |
| Acell, INC. | $13.87 | 2019 | |
| Covidien LP | $13.84 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.76 | 2020 | |
| Merck Sharp & Dohme LLC | $12.06 | 2020 | |
| Acera Surgical, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Iliya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.